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Although their exact function remains enigmatic, bifidobacteria are among the first colonizers of the
newborn infant gut and further develop into abundant communities, notably in response to diet. Therefore, the
transcriptional responses of bifidobacteria in rapidly processed fecal samples from young infants that were fed
either breast milk or a formula containing a mixture of galacto- and fructo-oligosaccharides were studied. The
presence and diversity of the bifidobacterial fecal communities were determined using PCR-denaturing gra-
dient gel electrophoresis and quantitative real-time PCR for specific species. Changes in the total number of
bifidobacteria as well as in species diversity were observed, indicating the metabolic activities of the bifidobac-
teria within the infant gut. In addition, total RNAs isolated from infant feces were labeled and hybridized to
a bifidobacterium-specific microarray comprising approximately 6,000 clones of the major bifidobacterial
species of the human gut. Approximately 270 clones that showed the most prominent hybridization with the
samples were sequenced. Fewer than 10% of the hybridizing clones contained rRNA genes, whereas the vast
majority of the inserts showed matches with protein-encoding genes predicted to originate from bifidobacteria.
Although a wide range of functional groups was covered by the obtained sequences, the largest fraction (14%)
of the transcribed genes assigned to a functional category were predicted to be involved in carbohydrate
metabolism, while some were also implicated in exopolysaccharide production or folate production. A total of
three of the above-described protein-encoding genes were selected for quantitative PCR and sequence analyses,
which confirmed the expression of the corresponding genes and the expected nucleotide sequences. In conclu-
sion, the results of this study show the feasibility of obtaining insight into the transcriptional responses of
intestinal bifidobacteria by analyzing fecal RNA and highlight the in vivo expression of bifidobacterial genes
implicated in host-related functions.
Following birth, the virtually sterile gastrointestinal tracts of
neonates become rapidly colonized by microbial communities,
collectively know as microbiota, which rapidly increase in com-
plexity (13). The vast majority reside in the colon, where den-
sities approach 1011 to 1012 cells per gram, the highest re-
corded for any microbial habitat (66). Here, hundreds of
bacterial species form a bacterial community in which bi-
fidobacterial species can constitute up to 60% of the total
population in infants (21). It has been shown previously that
various environmental factors affect the microbiota develop-
ment, including the feeding regimen of the infant (21). Bi-
fidobacteria are heterofermentative, nonmotile, non-spore-
forming rods; these gram-positive bacteria have high GC
contents in their genomic DNA and belong to the Actinobac-
teria phylum, within which they form a distinct order (5). At
present, the genus Bifidobacterium includes 32 species and 9
subspecies, many of which have been isolated from fecal
sources (60). The species most commonly isolated from sam-
ples obtained from breast-fed or formula-fed infants is Bi-
fidobacterium breve, followed by B. longum subsp. infantis, B.
longum, and B. bifidum (34). In addition, B. catenulatum, B.
adolescentis, B. pseudolongum, and B. dentium have been de-
tected but less frequently (20). It has been reported previously
that the postnatal maturation of a balanced immune system
requires constant microbial stimulation from the developing
intestinal microbiota (9, 23). Moreover, the intestinal micro-
biota has been claimed to have many beneficial effects, and
specifically, the bifidobacteria have been implicated in protec-
tion against pathogens (14), the normal development and
maintenance of a balanced immune system (9, 23, 55), and the
exertion of positive nutritional effects on the intestinal cells
and the host (43). In spite of the numerous studies on the
diversity of bifidobacteria in the human intestine, insight into
the specific activities and functions of bifidobacteria in the
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gastrointestinal tract remains very sparse. Most studies have
focused on molecular techniques targeting the 16S rRNA
genes, such as PCR-denaturing gradient gel electrophoresis
(PCR-DGGE) (52), fluorescent in situ hybridization (22),
quantitative real-time PCR (qPCR) (20), and more recently,
DNA microarrays (71), to identify and quantify the different
intestinal inhabitants of the gut. However, a new era has
started with the sequence characterization of bifidobacterial
genomes (61). In silico analysis of the total genome sequence
of B. longum NCC2705 predicted this bacterium to be adapted
to a special colonic niche (54). Several genes are predicted to
encode transcriptional regulators, which allow quick and strin-
gent responses to environmental changes. Moreover, some
genes are predicted to code for proteins that show homology to
glycoprotein-binding fimbriae, structures that may be involved
in adhesion and persistence in the gastrointestinal tract (54).
Unfortunately, only a few complete bifidobacterial genome
sequences have been reported, and only the full annotations of
the genomes of B. longum NCC2705 (54), B. longum DJO10A
(30), B. adolescentis ATCC 15703 (60), B. longum subsp. in-
fantis ATCC15697 (56), and Bifidobacterium animalis subsp.
lactis (26) have been made publicly available. A significant
portion of the genome of B. adolescentis differs from the ge-
nome of B. longum, reflecting the evolutionary difference be-
tween these species based on 16S rRNA genes. Genes coding
for lacto-N-biose (LNB) phosphorylase, 1,2--L-fucosidase,
and endo--N-acetylgalactosamidase, which are associated
with host-bacterial interaction, are absent in the B. adolescentis
genome, suggesting an alternative strategy for this species to
interact with the host (60).
Genomic sequences, however, provide only a static view, and
insight into the expression levels of the predicted genes in the
intestinal tract is not yet available. In the present study, we
investigated the feasibility of using rapidly processed fecal sam-
ples from infants to determine the bifidobacterial transcrip-
tome with a DNA microarray based on 6,000 clones from a
shotgun library, thereby bypassing the need for genome se-
quence information (45). This mixed-species microarray was
recently developed and used to study the transcriptome of B.
longum grown in vitro in the presence of human milk (17). To
improve our understanding of the interaction between bi-
fidobacteria and the host, fecal microbiotas of infants receiving
solely human breast milk and those receiving an infant formula
containing a mixture of galacto-oligosaccharides (GOS) and
fructo-oligosaccharides (FOS) (3, 37) were studied at the tran-
scriptional and diversity levels. The results reveal the expres-
sion of a selection of genes that may be related to the adaptive
responses of these species to the physiological gastrointestinal
conditions.
MATERIALS AND METHODS
Subjects. In a preliminary study, the transcriptomes of fecal microbiotas from
four infants ranging in age from 1 week to 10 months were evaluated to test the
feasibility of the selected approach for detecting the expression of protein-
encoding genes with the clone-based microarray described previously (15). High-
quality RNA preparations obtained from infants of various ages contained only
a low number of sequences complementary to rRNA (less than 10% of the total
hybridizing clones; data not shown). Hence, we systematically monitored two
breast-fed infants (infants 1 and 2) and three formula-fed infants (infants 3 to 5)
over time in a controlled dietary intervention. During the trial, the formula-fed
infants received a milk-based formula containing a mixture of GOS and long-
chain FOS (lcFOS) (9:1 [wt/wt]) (3, 37) that was provided by Danone Research,
Centre for Specialised Nutrition, Wageningen, The Netherlands. All infants were
healthy Caucasians delivered normally. Their ages at the start of the intervention
were on average 8 months (breast-fed infants 1 and 2 were between 6 and 7
months old, and formula-fed infants 3, 4, and 5 were between 6 and 10 months
old). They received solely breast or formula milk prior to and during the sam-
pling, in addition to small amounts of solid food after 6 months, as is common
practice in The Netherlands. The formula-fed infants received a standard for-
mula without GOS-lcFOS prior to the trial. The infants were monitored for up
to 8 weeks, and periodically, fecal samples were collected and processed as
described below. Written consent was obtained from the parents of each infant.
PCR-DGGE analysis and qPCR. DNA was isolated from mechanically dis-
rupted cells (68) from stool samples stored at 20°C and was purified using the
QIAamp DNA stool minikit (Qiagen Sciences, MD). PCR and DGGE analyses
of the V6-to-V8 regions of the 16S rRNA genes of the total microbial community
were performed as described previously using 16S rRNA gene-targeted primers
968-f/1401-r (40). The V6-to-V8 regions of the 16S rRNA genes of the bifidobac-
terial population were targeted using Im26-f/Im3-r, followed by Bif164-f/Bif662-
rGC (52, 69).
qPCR analysis of DNA extracts was performed in triplicate as described
previously (20) to obtain percentages for the total bifidobacterial community as
well as specifically B. adolescentis, B. angulatum, B. animalis, B. bifidum, B. breve,
B. catenulatum, B. dentium, B. longum subsp. infantis, and B. longum.
Total RNA isolation. Fecal samples were collected at three time points and
immediately mixed with RNAlater (Ambion Inc., Austin, TX) at a ratio of 1:2
(wt/vol), and the mixtures were incubated overnight at 4°C and stored at 20°C
until further processing as described previously (70).
Design and processing of a clone library-based DNA microarray. Glass spot-
ted microarrays were constructed as described previously (15) and contained
approximately 5,000 spots of 1- to 2-kb PCR amplicons that were derived from
plasmid inserts in genomic libraries of B. longum LMG 13197 (48), B. pseudo-
longum subsp. pseudolongum LMG 11571 (68), B. adolescentis LMG 10502 (48),
B. animalis subsp. animalis LMG 10508 (36), B. bifidum LMG 11041 (42), and B.
catenulatum LMG 11043 (53). Slides were stored in the dark under dust-free
conditions until further use. Before the addition of the hybridization mix, the
slides were prehybridized for 45 min at 42°C in a solution of 5 SSC (1 SSC
is 0.15 M NaCl plus 0.015 M sodium citrate) containing 0.1% sodium dodecyl
sulfate and 10 mg/ml bovine serum albumin, washed in MilliQ water and iso-
propanol, and then dried. Labeling, hybridization, and washing were performed
as described previously (46). In all instances, Cy3-labeled DNA sequences from
the bifidobacterial strains used to create the clone library were employed as a
reference.
Microarray analysis. The hybridized microarrays were analyzed with a Scan-
Array Express 4000 scanner (Perkin-Elmer). Fluorescent images were captured
in a multi-image-tagged image file format and analyzed with ImaGene software
(BioDiscovery, Marina del Rey, CA). As expected, labeled chromosomal DNA
of all bifidobacterial species on the microarray showed hybridization to virtually
all spots on the array. Spots that were flagged by the ImaGene software (Bio-
Discovery) were not included in the data analysis. In total, 5,314 spots met the set
quality criteria and were included in the analysis. For each spot, the mean signal
intensity was divided by the local background intensity and considered to indicate
positive hybridization when it was at least 1.25 times higher than the background.
The hybridization intensity values were normalized to the total intensity to
enable the comparison of results from different microarrays. Spots that did not
show positive hybridization to any of the cDNA samples were removed from
further analyses. Approximately 500- to 800-bp regions of both the 3 and 5 ends
of the inserts in selected clones were subsequently sequenced using primers SL1
and SR2, based on pSMART (GATC Biotech, Germany) (16). The Smith and
Waterman algorithm (57) was applied to evaluate the sequences against different
data sets. All sequences were analyzed against the complete protein and nucle-
otide sequences for all genomes with complete sequences present in the NCBI
repository (as of February 2009). In addition, specific searches were performed
using the complete genome sequences of B. longum NCC2705, B. adolescentis
ATCC 15703, B. longum subsp. infantis, and B. animalis subsp. lactis. Following
these searches, all matches with the genome sequences were analyzed for anno-
tated features by using the protein and RNA annotation files for the genomes.
Principal component analysis. Principal component analysis was performed
using Canoco software package 4.5 (Biometris, Wageningen, The Netherlands)
to assess the impact of diet on the microarray hybridization patterns of the total
RNAs isolated from the fecal microbiotas. Redundancy analysis (RA) was ap-
plied in specific cases to explain the contribution of the diet (breast milk or
formula) to the hybridization data (calculated as the hybridization intensity
divided by the local background intensity for each clone). Community similarities
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were graphed by using ordination plots with scaling focused on the dietary
difference. The ordination plot for species and environmental variables is char-
acterized by biplots that approximate the weighted averages for each species with
respect to the environmental variable (a diet of either breast milk or formula).
To test the significance of the relationship of the hybridization results with the
dietary group, unrestricted Monte Carlo permutation tests were performed with
499 random permutations and a significance level (P value) of 0.05.
qPCR. Primers were designed using Primer Express 1.5a (Applied Biosystems,
Nieuwerkerk aan den IJssel, The Netherlands), which also takes the presence of
secondary structures, including possible primer-dimers, into account. All primers
were designed to have melting temperatures of 60 to 70°C and amplicon sizes
between 70 and 130 bp. The specificities of the primers to bifidobacteria were
evaluated by nucleotide similarity searches with the BLAST algorithm for short,
nearly exact matches at the NCBI website (http://www.ncbi.nlm.nih.gov) (35). In
silico comparisons and PCR amplification products confirmed that primer sets
were specific for both B. longum NCC2705 and B. longum LMG 13197 but did
not target other organisms, including Lactobacillus plantarum WCFS1 and Esch-
erichia coli (data not shown). Target genes were the LNB phosphorylase
(BL1641) gene, with primer set AAC CGT ACA AGG ACG GAT TCG/CGG
AAT ATC GGC GAT CAT GC; the -L-arabinosidase (BL0544) gene, with
primer set TAC ACG CAA CGG CCA AGG/CCA GCA GGA CCA TCT GAC
C; and the thymidylate synthase (BL1665) gene, with primer set CAC GTG CAT
ATT TGG GAT GAG TG/CCA GGA ACG CCA CTG CAC. iQ Sybr green
supermix (Bio-Rad) was used in all reactions. The iQ5 real-time PCR detection
system (Bio-Rad) was used for all qPCR analyses. Each reaction was carried out
in a solution containing 5.0 l of cDNA, 12.5 l of power Sybr green master mix
(Applied Biosystems), the forward and reverse primers (2 M each), and 6.5 l
of distilled water. The PCR thermal protocol applied consisted of a 2-min 95°C
denaturation step, followed by 45 repeats of a 15-s denaturation step at 95°C, a
30-s annealing step (at a temperature defined for each primer set), and a 30-s
extension step at 72°C. A melting curve analysis was performed after the final
amplification period by using a temperature gradient from 60 to 95°C. Standard
curves for quantification were based on dilution series of DNA of B. longum
NCC2705. PCR products were sent to GATC Biotech (Germany) for purifica-
tion and sequencing to confirm the specific amplification of the target gene.
Microarray data. Raw microarray data are provided in File S2 in the supple-
mental material.
RESULTS AND DISCUSSION
Temporal stability and diversity of the predominant bacte-
rial community as determined by PCR-DGGE. The fecal mi-
crobiotas of infants are influenced by transitions between
breast milk, formula, and solid foods (4, 13, 21). Hence, prior
to gene expression studies, we compared the diversities of the
microbiotas, including bifidobacteria, in five partly age-
matched infants that were breast fed (infants 1 and 2) or
subjected to a diet of formula containing prebiotic oligosac-
charides (infants 3, 4, and 5). Both the expression of bifidobac-
terial genes (see below) and the bacterial diversity were ana-
lyzed over a period of 2 to 7 weeks, and samples were taken
periodically.
The diversities of the total fecal microbiotas and the bi-
fidobacterial populations were determined by DGGE analyses
of the 16S rRNA amplicons. Analyses of the diversities of the
bifidobacterial communities revealed relatively simple and sta-
ble patterns for both breast- and formula-fed infants. This
finding is illustrated for representative infants 2 and 5, of the
same age (6 to 7 months), who received breast milk and for-
mula, respectively, and showed the same dominant bifidobac-
terial species for several weeks (Fig. 1). In contrast, the DGGE
profiles representing the diversities of the total bacterial com-
munities from the breast-fed infants were much more stable
than those from the formula-fed infants. This finding is illus-
trated for the same infants whose results are presented in Fig.
2. This stability is especially notable when the sample time is
considered, as the community in the formula-fed infant fluc-
tuated considerably in a period of 2 weeks while that in the
breast-fed infant showed virtually the same microbial compo-
sition for 6 weeks. Similar observations were made with the
fecal samples from the other infants (data not shown).
As DGGE analysis of PCR amplicons is qualitative rather
than quantitative (71), a qPCR approach was used to deter-
mine the temporal development of the total number of bi-
fidobacteria (Fig. 3). This analysis showed that the total bi-
fidobacterial numbers in the breast-fed infants were higher
than those in the formula-fed infants at the start of the inter-
vention but that the numbers in the formula-fed infants in-
creased significantly over time, due possibly to the intake of the
oligosaccharide-containing formula (Fig. 3). qPCR analyses of
specific Bifidobacterium species indicated that there were few
significant differences between the breast- and formula-fed
infants and that numbers of these species in the breast-fed
infants were initially higher (Fig. 3). In samples from all in-
fants, B. animalis and B. dentium were not detectable and B.
angulatum was present in very low numbers. In addition, B.
longum subsp. infantis, B. breve, B. bifidum, and B. longum were
detected in samples from all infants, with B. longum subsp.
infantis being the major species found. B. adolescentis, which is
most commonly found in adults, was detected at a low propor-
FIG. 1. DGGE profiles of the fecal bifidobacteria from breast-fed
infant 2 (A) and formula-fed infant 5 (B) at different time points
(sampling days are indicated at the top).
FIG. 2. DGGE profiles of the fecal microbiotas of breast-fed infant
2 (A) and formula-fed infant 5 (B) at different sampling points (sam-
pling days are indicated at the top). The arrow identifies bands in the
gel that correspond to the bifidobacterial populations.
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tion in samples from the formula-fed infants but not at all in
those from infants receiving breast milk. In conclusion, these
analyses indicated that the samples from the formula-fed in-
fants contained fewer bifidobacteria than those from the
breast-fed infants but showed higher levels of diversity among
bifidobacterial species. During the period in which the infants
received the oligosaccharide-containing formula, the fecal bi-
fidobacterial diversities and quantities changed and ap-
proached those in the samples from the breast-fed infants,
which is in line with previous findings (29, 37).
Transcriptomes of the fecal bifidobacterial populations. To
gain insight into the activities of the bifidobacterial populations
within the fecal microbiotas, transcripts were profiled using a
mixed-species microarray of bifidobacteria (7). In parallel to
the fecal microbial diversity analysis, samples from the same
five partly age-matched infants (infants 1 to 5; see Materials
and Methods) with specified diets (breast milk or formula)
were compared using the microarray at three time points in a
2- to 7-week period. A total of 4,524 clones showed positive
hybridization of cDNA to at least one of the samples on the
microarray, and the total sums of the fluorescent signals were
comparable between arrays (data not shown). A selection of
the positively hybridized clones was sequenced and showed a
wide range of protein-encoding genes, indicating the metabolic
activities of the fecal bifidobacterial communities and the
power of this mixed-species clone library-based microarray.
It is important that the microarray consisted of cloned
genomic fragments derived from a mixture of six Bifidobacte-
rium spp. and that the hybridization took place under stringent
conditions—hence, the expression of only the cloned genes of
these specific strains or genes that have significant (generally
more than 80%) sequence similarity and, therefore, are pre-
dicted to have the same function as their cloned homolog could
be monitored.
Statistical analysis with the Canoco software package was
performed to identify whether host, environmental, or stochas-
tic effects explained the grouping of the studied samples. The
RA showed that 44% of the difference could be explained
significantly (P value of 0.004) by the difference in diet, either
breast milk or formula. The RA ordination plot for the hybrid-
izations of the three samples from infants 2 to 5 visualizes the
effects of the different diets (Fig. 4). The formula-fed infants
differed from one another more than the breast-fed infants
differed from each other, possibly because one of the formula-
fed infants was 3 months older than the other infants in the
group. However, all individuals within one diet group did not
differ significantly from one another (P values above 0.05). A
set of approximately 250 significantly hybridizing clones was
selected for sequencing to predict the functional identities of
the genes carried on the inserts. Most of the sequences ob-
tained (500 to 800 bp) did not include complete genes, but the
vast majority of the inserts (90%) matched closely (E value 
104) to already described bifidobacterial genes, and all ribo-
somal genes matched closely to bifidobacterial rRNA genes.
Less than 1% of the sequences were predicted to be noncoding
or could not be identified (data not shown). The sequences
appeared to encode a wide range of functions, such as those of
components of transport systems, energy metabolism, and car-
bohydrate metabolism (Fig. 5). Like the taxonomic assign-
ments, the identities of transcripts were inferred from the
closest matches. These assignments are only as good as the
existing database, and genes that are rare in genomes because
they code for unusual or specialized traits are particularly
susceptible to poor database coverage. The largest fraction of
transcripts (31%) was categorized as hypothetical, and these
transcripts were partly unclassified (typically having known
functions but not readily placed into a role category during
annotation). Among the corresponding genes may be those
encoding novel factors that allow the colonization of the hu-
man intestine by bifidobacterial species.
The inserts’ sequences present in the hybridizing clones on
FIG. 3. Total percentages of bifidobacteria in fecal samples from
infants who were breast fed (infants 1 and 2) or fed a standard formula
supplemented with GOS-lcFOS (infants 3, 4, and 5) as determined by
qPCR. The bars represent the standard errors of the means. The
percentages of bifidobacteria in the formula-fed but not in the breast-
fed group increased significantly compared to the baseline over time
(t1, start of analysis; t2, approximately 3 weeks later for breast-fed and
1 week later for formula-fed infants; and t3, an additional 1 to 2 weeks
later) as determined by Student’s t test (*, P  0.05).
FIG. 4. RA ordination plot comparing the total hybridization pat-
terns of fecal bifidobacterial transcriptomes obtained from breast-fed
infants (E; infants 1 and 2) and formula-fed infants (; infants 3, 4,
and 5) at different time points. Each sample is labeled with the iden-
tification number of the infant followed by the day of sampling. The
vector represents the diet variable.
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the microarrays were functionally annotated and grouped ac-
cording to the contribution of the gene expression values (sig-
nal over background) to the RA, as a measure for the impact
of each gene on the difference between the dietary groups (see
the supplemental material). The clones are listed in order of
importance for the clustering of the transcriptomes of the
infants’ microbiotas according to diet (formula or breast milk)
by using the hybridization signals for samples from infants 1 to
5 (Table 1). This means that the list starts with genes that have
a large influence on the deviation of the infants’ samples ac-
cording to the dietary group. The signals for the hybridization
to the clones at the end of the list do not indicate any impact
on the difference between the two dietary groups.
Active carbohydrate metabolism. The genome of B. longum
NCC2705 includes numerous genes for carbohydrate transport
and metabolism (54). These are collectively termed the glyco-
biome and show a preference for the metabolism of di-, tri-,
and oligosaccharides, pointing toward biased utilization for
complex oligosaccharides complemented with transporters for
a variety of disaccharides and oligosaccharides (44). The im-
portance of carbohydrate metabolism for the activity of bi-
fidobacteria in the intestinal tract is also evident from the
results of this study, as carbohydrate metabolism functions are
the most important category of predicted functions (Fig. 5),
corresponding to 14% of the genes, a proportion greater than
that determined by the sequence-based classification of carbo-
hydrate-active enzymes (8%) (60). Here, the most salient fea-
tures of the predicted bifidobacterial genes involved in intes-
tinal carbohydrate metabolism (the glycobiome) are discussed
briefly, with specific attention to those that are highly ex-
pressed, have the greatest impact on the RA, or are organized
into coexpressed operons (Table 1).
Taking the RA into account, the DNA fragment that had the
greatest impact on the difference between the two diet groups
included the B. longum lacZ gene (BL0978) that shows signif-
icant homology to the B. longum subsp. infantis HL96 gene
encoding -galactosidase I, which degrades lactose and other
sugars containing a -D-anomer-linked galactoside (24). Re-
cent growth studies with laboratory media showed the induc-
FIG. 5. Classification of the predicted functions of the 250 se-
quenced bifidobacterial inserts present on the microarray and showing
significant hybridization to the labeled total RNAs extracted from
infant fecal samples. KEGG, Kyoto Encyclopedia of Genes and Ge-
nomes.
TABLE 1. Hybridization values for glycobiome-related genes with significant hybridization signals in samples from infants 1 to 5a
Locus tag(s) Function(s) or identity(ies) ofgene product(s)
RA
result
(%)
Hybridization value for sample:
1-1 1-14 1-30 2-1 2-34 2-43 3-1 3-7 3-16 4-1 4-8 4-14 5-1 5-7 5-14
BAD_0708 Pullulanase 12.89 39.61 41.89 33.60 67.83 92.57 64.86 12.05 2.82 ND 39.58 4.16 6.27 ND 37.04 2.28
BAD_1412 Probable sugar kinase 12.25 1.89 1.89 ND 1.51 1.84 1.50 1.34 1.32 ND 2.02 1.36 1.33 ND 3.20 1.53
BAD_1527 Endo-1,4--xylanase 9.74 ND 1.74 ND 1.31 1.58 ND 1.58 ND ND ND ND ND ND 2.28 1.29
BAD_1605 -Galactosidase 3.01 ND 1.36 ND ND 1.36 ND ND ND 1.28 ND ND ND 1.65 1.79 1.80
BL0146 Possible arabinosidase 12.39 ND 2.43 ND 1.59 1.36 1.30 1.26 ND ND ND ND ND 2.16 ND 1.45
BL0421 Narrowly conserved HP possibly
involved in xylan degradation
12.81 ND 1.53 ND ND 1.31 1.39 1.28 ND ND ND 1.32 ND ND 1.33 1.45
BL0529 Probable -1,4-glucosidase;
maltase-like enzyme
22.79 1.58 1.90 ND ND 2.60 ND 2.08 ND ND ND ND ND 2.54 2.82 1.68
BL0536 Sucrose phosphorylase 0.05 2.08 1.95 1.27 2.21 2.50 2.08 1.32 2.03 ND 1.36 ND 1.68 3.46 4.63 ND
BL0544 -L-Arabinosidase 24.40 ND ND 1.37 1.30 1.46 1.10 1.38 ND ND 1.27 ND ND 0.99 1.59 2.40
BL0597 Glycogen phosphorylase 86.10 245.91 208.05 200.41 217.36 150.31 166.54 80.33 34.42 ND 5.77 8.25 26.81 1.94 97.23 39.30
BL0715 Transaldolase 1.23 12.99 10.18 3.94 8.64 22.69 36.03 9.99 2.45 ND 24.63 1.37 3.33 46.41 63.17 25.69
BL0716 Transketolase 5.75 1.33 1.27 ND ND 1.73 ND ND ND ND 1.46 ND ND 1.29 ND ND
BL0978 Glycosyl hydrolase (LacZ) 90.9 30.91 46.13 43.51 41.34 59.71 51.23 10.01 1.99 ND 7.47 ND 2.95 ND 10.41 6.60
BL1104 Possible glycosyltransferase 12.77 2.93 1.60 1.86 5.92 4.10 2.65 1.73 ND ND 1.28 1.63 3.90 4.85 2.43 34.88
BL1308 Lactate dehydrogenase 0.17 1.49 1.69 ND 1.26 1.52 ND 1.49 ND ND ND ND 1.27 ND 4.10 1.26
BL1518 -Galactosidase 28.8 ND 1.29 ND ND ND ND 1.42 ND 1.33 ND ND ND 1.71 1.25 ND
BL1638 Solute-binding protein of ABC
transporter for sugars
4.28 1.33 1.44 ND ND 1.73 ND 1.52 ND ND ND ND ND 1.52 1.82 ND
BL1639 Permease of ABC transporter
for sugars
14.37 ND ND 1.37 ND 1.38 1.27 1.38 ND ND 1.27 ND ND 1.82 2.92 3.16
BL1641 LNB phosphorylase 5.61 ND ND ND ND ND ND ND ND 2.30 ND ND ND ND ND ND
BL1643 and
BL1644
Galactose-1-phosphate
uridylyltransferase and UDP-
glucose 4-epimerase
0.42 ND ND ND ND 1.39 ND 1.26 ND ND ND ND ND 1.31 1.36 ND
BL1674 Probable glycosyltransferase 1.76 1.64 1.35 ND 1.26 2.76 1.34 2.21 1.31 ND ND ND 1.39 2.87 4.27 1.56
a Significant hybridization signals were those for which signal/background ratios were 	1.25. Infants 1 and 2, for which sample designations are identified in bold,
were breast fed. Sample designations indicate the infant identification number and the day of sampling. ND, not detected (no significant hybridization signal detected);
HP, hypothetical protein.
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tion of the B. longum lacZ gene by lactose, maltose, and FOS
(44). In the present study, the lacZ-like gene showed greater
expression in breast-fed infants, though a clone with a very
similar gene, BAD_1605, showed much lower hybridization
signals than those for the lacZ-like gene, indicating the signif-
icance of the encoded -galactosidase in intestinal sugar deg-
radation. Similarly, the RA value for the fragment including
BL0597 (coding for a glycogen phosphorylase) is high, and this
gene is involved in the breakdown of starch into glucose units.
The -1,6 bonds in amylopectin, glycogen, and pullulan can be
hydrolyzed by so-called pullulanases (encoded by BAD_0708),
which were previously shown to be expressed in several bi-
fidobacterial species growing on these sugar polymers in lab-
oratory media (41, 49). The latter genes show higher hybrid-
ization levels in breast-fed infants than in formula-fed infants.
A bifidobacterial -L-arabinosidase-like gene (BL0544, or
abfB) was found to be expressed in all of the infants. The abfB
gene encodes a hemicellulose-degrading enzyme that hydro-
lyzes terminal -L-arabinofuranosyl groups from arabinose-
containing oligosaccharides and polysaccharides such as arabi-
nans, arabinoxylans, and xylans, major components of plant
cell walls (50). It is known that -arabinofuranosidases, to-
gether with other hydrolases with endo- and exoactivities, are
required for the complete degradation of polymeric carbohy-
drates. These substrates are poorly digested by the host or
other intestinal microbes. The sequencing of the B. longum
genome (54) allowed the annotation of at least 14 different
enzymes with hypothetical roles in the catabolism of arabinose-
containing polymers, which corroborated the importance of
these types of enzymes and polysaccharides in the metabolisms
of some bifidobacteria. The expression of the abfB-like gene
and the influences of inducers and repressors in B. longum
NIZO B667 have been studied, and the findings have indicated
transcriptional regulation. Degenerate primers revealed the
widespread presence of the -arabinofuranosidase enzyme
family (family 51 of glycoside hydrolases) in B. longum, B.
longum subsp. infantis, B. animalis, and B. bifidum (19). A
different gene, possibly coding for an arabinosidase (BL0146),
was found to have hybridization levels similar to those of abfB-
like gene and may also be involved in the breakdown of arabi-
nose-containing saccharides. AbfB activity indicates a selective
advantage for bifidobacteria for nutritional competition in and
the colonization of the human gastrointestinal tract, as arabi-
nose-containing polymers, such as hemicellulose and pectin,
are abundant in the human diet and are known to reach the
colon. The expression of arabinosidases by the bifidobacterial
community may give these species an advantage to survive and
colonize the human colon. As the infants that received only a
breast milk-based diet also showed the expression of an abfB-
like gene, it is possible either that breast milk contains arabi-
nose-like sugars or arabinose-decorated glycoproteins or that it
contains related sugars that act as inducers of abfB-like gene
expression. An alternative explanation is that milk serves as a
substrate for the growth of microbes that produce arabinose-
like compounds.
The novel putative operon for galactose metabolism
(BL1638 to BL1644) was detected in the B. longum clone
library by the hybridization of RNAs from both breast-fed and
formula-fed infants. This operon is involved in the breakdown
of structures present in mucin sugars (10, 39, 63), indicating a
way for bifidobacteria to colonize the intestine. Additionally,
the complex mixture of human milk oligosaccharides contains
LNB structures (27, 65) broken down by the products of the
genes in this operon; BL1638 to BL1640 genes are annotated
as encoding component proteins of the ABC-type sugar trans-
porter, and the BL1641 gene is annotated as encoding LNB
phosphorylase. The cluster of BL1642, BL1643, and BL1644
genes, which were annotated as encoding mucin desulfatase,
galactose-1-phosphate uridylyltransferase, and UDP-glucose
4-epimerase, respectively, likely codes for a metabolic pathway
for mucin sugars, because galacto-N-biose is the core structure
of mucin-type sugars (10). In this pathway, galactose 1-P,
formed by the phosphorolysis of LNB/galacto-N-biose, is con-
verted into UDP-glucose. Other genes involved in carbohy-
drate metabolism are predicted to encode an -1,4-glucosidase
(BL0529) and an -galactosidase (BL1518), both of which are
expressed to a greater degree in formula-fed infants than in
breast-fed infants. Finally, a lactate dehydrogenase gene
(BL1308), involved in the final step in anaerobic glycolysis and
the formation of lactate, was found to hybridize to RNAs
isolated from both formula- and breast-fed infants, reflecting
the activity of bifidobacterial sugar metabolism.
An endo-1,4--xylanase gene (BAD_1527) and a hypothet-
ical gene involved in xylan degradation (BL0421) may be in-
volved in the breakdown of xylans by the hydrolysis of 1,4--
D-xylosidic linkages in xylans. The two genes were detected in
samples from all infants and show similar hybridization signals.
The BAD_1412 product, a probable sugar kinase, has high
levels of similarity to xylose kinases and may be involved in the
breakdown of xylans as well. Sucrose phosphorylase (encoded
by the BL0536 gene) breaks down sucrose and is involved in
energy metabolism.
Overall, the expression of the glycobiome (Table 1), espe-
cially the genes encoding pullulanases, -1,4-glucosidase, and
the glycogen phosphorylase, indicates a higher potential for
carbohydrate metabolism in breast-fed infants than in formula-
fed infants. This finding may very well be explained by the high
degree of diversity of complex oligosaccharides in human milk
(6, 38) that activate and/or increase the abundance of species
expressing these genes.
Colonization factors. Streptococcus mutans 20381 is known
to use glycosyltransferases to form polysaccharides, which are
involved in the formation of biofilms and have been shown
previously to be the major contributors to adherence (67). In
this study, the expression of two putative glycosyltransferases,
the BL1104 and BL1674 products, was detected in most of the
samples, suggesting the in vivo production of polysaccharides
that may also play a role in biofilm formation and the coloni-
zation of the host’s intestine by bifidobacteria. A possible pen-
icillin-binding protein (encoded by BAD_1336) is predicted to
be involved in the synthesis of peptidoglycan, is the major
component of bacterial cell walls (31), and may be involved in
the recognition of the bacteria by the host. Only samples from
formula-fed babies showed hybridization to the clone contain-
ing BAD_1336 (see File S1 in the supplemental material).
Activity of bifidobacteria within the human intestine. Sev-
eral other genes and operons are worth mentioning, as these
are biologically relevant and may explain functions of the in-
testinal bifidobacteria related to host interaction and coloni-
zation and competition within the intestinal microbiota. The
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gene for transaldolase (BL0715), which takes part in the non-
oxidative phase of the pentose phosphate route, was expressed
in samples from all infants. Its translation product was also
detected in the metaproteomes from infant feces (28) and the
proteome of B. longum subsp. infantis BI07 grown in a labo-
ratory medium (62). The gene for transketolase (BL0716), also
involved in the pentose phosphate route characteristic of bi-
fidobacterial metabolism, was expressed at lower levels than
the gene for transaldolase.
Hybridization to the clone containing BTH_II0919, coding
for a glutamine-dependent NAD synthetase (EC 6.3.5.10),
indicates the presence of a glutamine-rich substrate. A previ-
ous study showed increased intestinal bifidobacterial numbers
upon the intake of prebiotics containing glutamine-rich protein
by healthy adults (25). Glutamine is known to be among the
nutrient requirements for infant gut maturation, as the endog-
enous capacity to synthesize glutamine from glutamate is not
fully developed. The lower hybridization levels for samples
from formula-fed infants may be due to lower glutamine levels
in the formula than in breast milk (1).
Several genes predicted to be involved in folate biosynthesis
pathways were found to be expressed, namely, those encoding
dihydrofolate reductase (BL1666) and thymidylate synthase
(BL1665), involved in the last step of the production of folate.
Folate is involved in many metabolic pathways, such as methyl
group biogenesis and the synthesis of nucleotides, vitamins,
and some amino acids. It has been demonstrated previously
that folate synthesized by bacteria in the human intestine is
absorbed and used by the host (51). Moreover, several bi-
fidobacterial species have been found to produce folate in
laboratory media (47). The expression of genes encoding folate
in the infants’ intestinal tracts indicates the in vivo production
of this vitamin, which is beneficial to the host and can be
absorbed through the large intestine (47). Remarkably, the
levels of hybridization of folate biosynthesis-like genes in sam-
ples from formula-fed infants were found to be slightly higher,
but not significantly so, than those in samples from breast-fed
infants.
The gene for a putative copper-transporting ATPase
(BL0409) was expressed mostly in samples from formula-fed
infants, and its translation product was also found in the pro-
teome of B. longum subsp. infantis (62). In a recent study, a
transcriptome analysis of L. plantarum indicated significant
expression of a gene for an orthologous putative copper-trans-
porting protein in intestinal samples from humans (11) and
mice (8), but the function is not confirmed.
qPCR and sequencing analyses. Using the clone insert se-
quences and matching sequences in the database, primer sets
for qPCR were designed to target the thymidylate synthase
(BL1665) gene, BL1641, and the -L-arabinosidase (BL0544)
gene, and qPCR analysis of cDNAs was performed to confirm
the specific hybridization of transcripts to the microarray.
Melting curves showed specific amplification of one product
for each sample primer set combination (data not shown).
The quantification of gene activity can be complicated be-
cause it is not known how many active bifidobacteria with
sequences that match the amplicons spotted onto the microar-
ray are present in the samples. The yield of RNA per sample
unit was found to differ among samples and individuals be-
cause of transit time, diet, and other host-related conditions.
The sizes of the gene fragments on the microarray can also
cause variability in hybridization among samples from different
origins. However, the relative copy numbers obtained with
qPCR showed trends similar to those demonstrated by the
relative signal-to-background ratios obtained with the microar-
ray hybridizations, confirming the presence of target mRNA
(data not shown). Moreover, sequence analyses of the ampli-
cons from qPCR confirmed the amplification of the target
genes BL1665, BL1641, and BL0544.
Concluding remarks. This study revealed that bifidobacte-
rial species undergo dynamic changes in infant feces at the
level of persistence as well as their functional complements. To
aid the detection of the gene transcript, the numbers and
diversities of bifidobacteria in the infants’ feces were deter-
mined using molecular tools. This approach was comple-
mented by transcriptome analysis using mixed-bifidobacterial-
species microarrays that showed a significant impact of diet on
the transcriptional responses of bifidobacteria in breast- and
formula-fed infants.
Genome-wide transcript analyses using DNA microarrays
provide opportunities for comprehensive and integrative views
of bacterial activities occurring within the intestinal tract. The
potential of this approach was exemplified by previous studies
reporting full-genome transcriptome profiles for Bacteroides
thetaiotaomicron and B. longum residing in the ceca of germ-
free mice (58, 59), as well as for L. plantarum in conventional
mice (32). In the present study, the hybridization profile could
be used to assess the influence of the diet on the transcrip-
tomes of fecal bifidobacterial communities from infants. Par-
ticularly, the use of a mixed-species microarray made it possi-
ble to simultaneously target several bifidobacterial species in
the complex fecal microbial ecosystem. By using this array, it
was possible to compare fecal bifidobacterial gene expression
profiles for individuals despite the unique fecal microbial com-
positions.
Samples from breast-fed infants with stable total microbiotas
and bifidobacterial populations showed variety in transcripts at
different time points, indicating active bifidobacterial popula-
tions. As expected, the transcriptomes of microbiotas in the
formula-fed infants, with more unstable microbial diversity,
also showed differences over time. The observed differences
may have been caused by the variation of activities of individ-
ual bifidobacterial species and/or environmental factors such
as diet. Possibly, host factors and the addition of solid food to
the milk diet also had an influence, and hence, more individ-
uals should be compared. It is likely that specific bifidobacte-
rial species may be a target of modulation by prebiotics, but
this study did not reveal a direct link between the expressed
genes and the species. The genome sequence of B. longum
NCC2705 revealed that the chromosome includes numerous
genes for carbohydrate utilization, specifically those for over 30
glycosyl hydrolases that are predicted to be involved in the
degradation of higher-order oligosaccharides (54), and 19 car-
bohydrate transport systems were proven to be active in labo-
ratory media (44). B. adolescentis MB 239 prefers lactose, FOS,
and raffinose over glucose and fructose in laboratory media,
which was explained by -galactosidase, -galactosidase, and
-fructofuranosidase activities (2). The findings of this study
show that at least a portion of these genes are being tran-
scribed in vivo in the infant intestinal tract. This gene expres-
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sion may give these bifidobacteria advantages in colonizing the
infant gut and explains the growth-promoting effect of oligo-
saccharides which are described as prebiotics.
The sequencing of an extensive metagenomic library from
the human distal gut revealed a high degree of diversity in
bifidobacterial genes compared to the B. longum NCC2705
genome (15). This finding suggests the presence of multiple
and related bifidobacterial strains. The presently known and
expected sequences of several bifidobacterial genomes will
open up a new era of comparative genomics and provide a
basis for the setup of a molecular model that can predict the
bifidobacterium-host interaction. This progress will improve
the molecular studies of the functional complement with tools
such as transcriptomics, described here, as well as metapro-
teomics (28) and metabolomics (18). The further development
of high-throughput sequencing techniques will allow the de-
tection and quantification of total cDNAs without the limita-
tion of relevant probes on a microarray (33, 64).
Ultimately, this advancement will lead to a detailed under-
standing of the nutritional lifestyle of bifidobacteria and its
impact on the host. Linking the functional activities of intesti-
nal bifidobacteria to specific groups of healthy or diseased
individuals or special diets will open up leads for the modula-
tion of the intestinal bifidobacterial community, exerting
health benefits.
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